Table 4.
QLQ-BLM30
| QLQ-BLM30 | Ileal conduit Mean ± standard dev. Median (interquartile range) n = number of cases |
Ileal neobladder Mean ± standard dev. Median (interquartile range) n = number of cases |
|---|---|---|
| Urinary symptom | 33.6 ± 26.3 | |
| 33.3 (9.5–52.4) | ||
| n = 33 | ||
| Urostomy problem | 25.6 ± 22.0 | |
| 19.4 (6.9–43.8) | ||
| n = 24 | ||
| Single catheter use problem | 0 ± 0 | 6.7 ± 14.9 |
| 0 (0-0) | 0 (0–16.7) | |
| n = 1 | n = 5 | |
| Future perspective | 39.1 ± 33.8 | 24.3 ± 27.9 |
| 33.3 (11.1–66.7) | 11.1 (0–44.4) | |
| n = 23 | n = 32 | |
| Abdominal bloating and flatulence | 28.3 ± 25.8 | 29.7 ± 31.0 |
| 33.3 (0–50.0) | 16.7 (0–50) | |
| n = 23 | n = 32 | |
| Body image | 34.1 ± 32.3 | 33.5 ± 28.2 |
| 22.2 (11.1–55.6) | 33.3 (11.1–55.6) | |
| n = 23 | n = 32 | |
| Sexual functioning | no available data | no available data |
EORTC QLQ-BLM30 results of this study. The questionnaire is a phase-3 module that specifically evaluates the impact of radical cystectomy and reconstructive surgery in terms of health-related quality of life. For all the questions, a scale from 1 to 4 was used (1: not at all, 2: a little, 3: quite a bit, 4: very much). All scores were linearly transformed such that all scales range from 0 to 100. For the symptoms/single items, a higher score means a higher level of symptomatology/problems.